FDA approves Medtronic’s Consulta, Syncra pacemaker systems
Medtronic Inc. has started shipments of its newest line of pacemaker systems Consulta and Syncra now that the devices have won U.S. Food and Drug Administration approval. Fridley, Minnesota-based Medtronic (NYSE: MDT) said Wednesday that both Consulta and Syncra include technology that allows for remote follow-up of heart patients implanted with the stopwatch-sized devices. The […]